CN104415187A - Medicine for lowering hyperlipidemia by employing pure traditional Chinese medicines - Google Patents
Medicine for lowering hyperlipidemia by employing pure traditional Chinese medicines Download PDFInfo
- Publication number
- CN104415187A CN104415187A CN201310407448.0A CN201310407448A CN104415187A CN 104415187 A CN104415187 A CN 104415187A CN 201310407448 A CN201310407448 A CN 201310407448A CN 104415187 A CN104415187 A CN 104415187A
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- hyperlipidemia
- processed
- lowering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Insects & Arthropods (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for lowering hyperlipidemia by employing pure traditional Chinese medicines. In order to solve the problems that a patient takes trouble to decoct medicine every day and the decoction is bitter in taste and difficult to swallow, the invention provides a Chinese patent medicine preparation which is capable of promoting blood circulation to remove blood stasis and lowering hyperlipidemia and is convenient to take. The medicine is prepared from 22 natural traditional Chinese medicines, including hawthorn, processed fleece-flower root, leech, clean lumbricus (lumbricus with soil dirt removed), Chinese polyphaga, astragalus membranaceus, salviae miltiorrhizae, red peony root, peach kernel, flowers carthami, ligusticum wallichii, rheum officinale, tuber fleeceflower stem, caulis spatholobi, lignum dalbergiae odoriferae, processed frankincense, processed myrrh, fruits of Chinese wolfberry, semen euryales, white poria and rhizoma alismatis. Last ten years, over 3,000 cases of patients with diabetes complicated by hyperlipidemia are treated with the components of the medicine by the applicant; 100 cases of patients are reserved; the effective rate after keeping taking for a month is over 95%; the effective rate for lowering blood fat and cholesterol and the complete normal rate after keeping taking for 3-6 months are both 100%; and the medicine is commended to be a real 'vascular scavenger' by many patients which have used the medicine.
Description
Art
This medicine is that applicant effectively treats the pure Chinese medicinal preparation of hyperlipidemia in medical domain invention.Arrive according to applying for a patent people's clinical observation, the patient that hyperlipidemia is suffered from by current China gets more and more, and cause the heart by hyperlipidemia, cerebrovascular disables and (as to can't take care of oneself, losing the job or the hemiplegia of work capacity) patient also gets more and more, for solving the misery because hyperlipidemia brings to extensive patients, applying for a patent people spy and researching and developing with great concentration this medicine.This medical instrument has the effects such as obvious blood fat reducing, cholesterol reducing, blood circulation promoting and blood stasis dispelling, blood vessel dilating, removing obstruction in the collateral to relieve pain, inducing diuresis to remove edema, stabilizing blood sugar; And there is instant effect, the technical characteristics such as taking convenience.Many hyperlipemic patients of having cured, claim this medicine to be only real " blood vessel street cleaner ".
Background technology
Applicant is engaged in tcm internal medicine clinical more than 30 years, original mainly with Chinese herbal treatment diabetes (doctor trained in Western medicine claims diabetes).The first years of a historical period due to experience still shallow, just to the leading tentative diagnosis of diabetes, dialectical treatmert, found that the diabetes patient of more than 90% was all associated with the situation of hyperlipidemia originally.Since nineteen ninety-eight, all come clients must first chemically examine blood glucose, blood fat.So far just there is the situation of hyperlipidemia in the every diabetes patient of real discovery most likely.Not only control diabetes but also can the effect of blood fat reducing for reaching, add blood activating and fat reducing medicine in prescription after, its curative effect significantly improves than in the past.This is my clinical experience realized.For the more people of health, spy invents, declares this patent.
Summary of the invention:
For solving patient's trouble of boiling medicine and flavour of a drug suffering of eating soup pharynx problem everyday, the invention provides one can blood circulation promoting and blood stasis dispelling, reduces blood fat, the again Chinese patent medicine preparation of taking convenience.This medicine by Fructus Crataegi, Radix Polygoni Multiflori Preparata, Hirudo, pure land dragon (go soil assorted Pheretima), Eupolyphaga Seu Steleophaga, the Radix Astragali, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Semen Persicae, Flos Carthami, Rhizoma Chuanxiong, Radix Et Rhizoma Rhei, Caulis Polygoni Multiflori, Caulis Spatholobi, Lignum Dalbergiae Odoriferae, Olibanum (processed), Myrrha (processed), Fructus Lycii, Semen Euryales (individual), Poria, totally 22 kinds of natural Chinese medicines are formulated for Rhizoma Alismatis.And by 22 kinds of Chinese crude drug gross weights 100% to calculate by weight percentage, the percentage ratio of each medicine is: Fructus Crataegi 15%, Radix Polygoni Multiflori Preparata 15%, Hirudo 6%, pure land dragon (going the assorted Pheretima of soil to be pure land dragon) 6%, suppress worm 6%, the Radix Astragali 6%, Radix Angelicae Sinensis 6%, Radix Salviae Miltiorrhizae 6%, Radix Paeoniae Rubra 3%, Semen Persicae 3%, Flos Carthami 3%, Rhizoma Chuanxiong 3%, Radix Et Rhizoma Rhei 3%, Caulis Polygoni Multiflori 3%, Caulis Spatholobi 3%, Lignum Dalbergiae Odoriferae 1%, Olibanum (processed) 1%, Myrrha (processed) 1%, Fructus Lycii 3%, Semen Euryales (individual) 2%, Poria 3%, Rhizoma Alismatis 2%.
Compound method comprises the following steps composition:
1. first Fructus Lycii is dried separately or dry for standby.
2. on clean threshing ground, fully mixing even i.e. available pulverizer with Fructus Lycii be ground into fine powder by drying other 21 kinds of medical materials load weighted again, crossing 80 mesh sieves (also can in pulverizer directly at the bottom of installation 80 order sieve for saving manpower).
3. the pill of every ball 0.2-0.3g size is made with pellet processing machine.
4. the pill of drying is entered bottle, then seal with sealing machine.
5. instructions of taking: every day 2-3 time, each 3-9g, warm water or soup take after the meal.
In a word, this medicine not only processing technology is very simple, easy to perform, and curative effect really earnestly, and all hyperlipemic patients taking this medicine do not have a routine disappointed person.The technical problem solved:
At present, the cardiovascular and cerebrovascular disease that China causes because of hyperlipidemia is disabled, and (as hemiplegia of the can't take care of oneself ability of losing the job and work capacity) patient gets more and more, it will affect and restrict the paces of China's all-round construction development, for the harm that control hyperlipidemia brings, China urgently puts into effect the good medicine effectively treating hyperlipidemia.
Beneficial effect:
The blood fat reducing medicine be made up of 22 taste natural Chinese medicines has blood circulation promoting and blood stasis dispelling significantly, alcohol lipid-lowering effect falls, we are not doing any type of publicity, under only passing on from one to another situation by patient's public praise, since nineteen ninety-eight through merging hyperlipemic patients observation of curative effect to see and treat patients more than 3000 routine diabetes (diabetes), adhere to that the effective percentage taking month reaches more than 95%, adhere to that the complete natural rate of interest taking 3-6 month all reaches 100%.With this medicine in treatment angina pectoris, adhere to that the effective percentage taking 1 month reaches 77%, adhere to that the complete control rate of symptom taking 3-6 month reaches 100%, and not easily recur.
Model case (one) Pang Yuzhen, female, 60 years old is the adopted stockaded village village people of Lankao County three, and on June 2nd, 2011 comes me and hospital specially looks for this human therapy of applicant because for the treatment of diabetes, angina pectoris, is assisted in the outpatient service of coming into me by sons and daughters.Inscribe inspection: express one's feelings dispirited, face dolorosa, eyelid and the obvious edema of lower limb; Inquiring: private prosecution at ordinary times pareordia take place frequently squeezing property angor, can not manage household affairs; Inspection of the tongue: purple spots at the margin and tip of the tongue.Inscribe chemical examination: cholesterol 5.68mmol/L (normal value 3.1-5.2), triglyceride 5.48mmol/L (normal value 0.4-1.7), blood glucose 14.64mmol/L (normal value 3.9-6.1), is diagnosed as diabetes and hyperlipidemia complications angina pectoris.Then throw this medicine composition to observe one week.
10 days two June in 2011 examines, and oneself can come into outpatient service, inscribe inspection: expression is happy, and eyelid and edema of lower limbs obviously alleviate.Inquiring: private prosecution angina pectoris number of times obviously reduces.Inscribe result of laboratory test: cholesterol 3.9mmol/L (normal), triglyceride 1.58mmol/L (normal), blood glucose is down to 7.69mmol/L by the 14.64mmol/L of first visit.See after result of laboratory test, patient's expression is very happy, praises: " curative effect of your this medicine is really too magical; ate in the past and much rescue heart blood lipid-reducing blood sugar-decreasing and control swollen medicine; through repeatedly chemically examining never normal mistake, really unexpected lipid lowerers of only eating you is normal once week, be really too mystery ".[see rear attached laboratory test report] also advises its decrement to adhere to taking 3 ~ 6 months consolidate curative effect again.By repeatedly paying a return visit, stable disease, can manage household affairs, not have angina pectoris more always.
Case (two) Wang Yu comes, and man, 48 years old is Lankao County area just outside a city gate people from town.On May 7th, 2011 specially looks for this human therapy of applicant diabetes clinic because of my hospital that comes, and inscribes inspection: lassitude, obviously becomes thin.Chemical examination: blood glucose 11.71mmol/L (normal value 3.89-6.11), triglyceride 2.34mmol/L (normal value 1.7mmol/L), then throws this medicine and takes 2 weeks observe the curative effect.
Further consultation on May 21 in 2011, result of laboratory test: blood glucose 7.8mmol/L (being clearly better), triglyceride 1.46mmol/L (normal).After having seen laboratory test report, patient's private prosecution finds that hyperglycemia hyperlipidemia has several years, is all at will buy a little blood sugar lowering in pharmacy at ordinary times. lipid lowerers, take medicine everyday, but never real normal mistake, say: " seeming that your this medicine is also very very effective ".[seeing below attached laboratory test report]
Case (three) Yang Zimei, female, 40 years old is that Lankao County paddy battalion village people is transferred in Yunan border areas county.July 1 in 2011, Yin Zhi diabetes carried out my hospital admission.Inscribe inspection: lean body mass, lethargy.Result of laboratory test is: cholesterol 6.07 (normal value 3.1 ~ 5.2) mmol/L, triglyceride 2.13 (normal value 0.4 ~ 1.70) mmol/L, HDL1 .73 (normal value 1.16 ~ 1.55) mmol/L.Glucose 17.7 (normal value 3.89 ~ 6.1) mmol/L, throws this medicine 2 Zhou Guanxiao then.
Further consultation on July 13 in 2011, result of laboratory test is: cholesterol 4.6 (normal) mmol/L, triglyceride 1.58 (normal) mmol/L, HDL1 .51 (normal) mmol/L.Blood glucose 13.76 (taking a turn for the better) mmol/L.Say when patient takes laboratory test report: " originally ate the medicine of blood sugar lowering blood fat reducing, and eaten several years everyday, often chemical examination but once also abnormal mistake, originally also hearing of Zhang doctor treating in hyperlipidemia has unique skill, and I did not believe at that time.In treatment hyperlipidemia, really unique skill is had to Zhang doctor " through my ability firsthand experience of current treatment.It is advised to adhere to taking 3 months consolidate curative effect in a small amount again.[seeing below attached laboratory test report]
Case (four): Guo Hui, man, 31 years old is Lankao County area just outside a city gate village people.On August 18th, 2011 is because carrying out my hospital's check diabetes clinic.Inscribe chemical examination: triglyceride 9.77 (normal value 0.4 ~ 1.7) mmol/L.Glucose 7.16mmol/L.Then throw this medicine and take 2 weeks observe the curative effect.Patient, in JIUYUE in 2011 further consultation on the 1st, inscribes chemical examination: triglyceride 3.0mmol/L.Glucose 6.78mmol/L.In medicine, pathogenesis has good effect.It is advised to adhere to taking 2 months consolidate curative effect again.[seeing below attached laboratory test report]
Case (five): Xiao Xiang, female, 56 years old is Lankao County instrument envelope village people.Patient carries in December in 2011 and carried out my hospital admission out of admiration for a famous person at the laboratory test report of other hospitals on the 21st yesterday.Result of laboratory test shows: cholesterol 6.98 (normal value 5.2) mmol/L.Triglyceride 6.58 (normal value 1.7) mmol/L, glucose 11.0 (normal value 3.9 ~ 6.1) mmol/L.Then throw this medicine and take 3 weeks observe the curative effect.Further consultation on January 12 in 2012, I was busy not in outpatient service at that time, advised it first allow other doctor prescribed laboratory test reports.Result of laboratory test is: blood glucose is down to 5.55mmol/L by 11.0mmol/L during first visit, triglyceride is down to 2.42mmol/L by the 6.58mmol/L of first visit, and cholesterol has been down to 3.83 (normal value 3.1 ~ 5.2) mmol/L by the 6.98mmol/L of first visit.After seeing result of laboratory test, patient praises endlessly the curative effect of this medicine.[seeing below attached laboratory test report]
" a kind of medicine reducing hyperlipidemia with pure Chinese medicine " is clinically only so repeatly with imitating repeatly, because of blood circulation promoting and blood stasis dispelling in applicant general at all times medical science well-known doctor masterpiece, the experience Jin Ji of Antilpemic and thrombolytic is a side, as Fructus Crataegi used in side, Radix Polygoni Multiflori Preparata, Hirudo, pure land dragon, Eupolyphaga Seu Steleophaga, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Semen Persicae, Flos Carthami, Rhizoma Chuanxiong, Radix Et Rhizoma Rhei, Caulis Spatholobi, Caulis Polygoni Multiflori, Olibanum (processed), Myrrha (processed), be the blood circulation promoting and blood stasis dispelling thrombolysis lipid-lowering medicine that well-known doctor at all times commonly uses clinically, especially be the guide medicine of blood circulation promoting and blood stasis dispelling with Radix Et Rhizoma Rhei in side, it can lead all drug for invigorating blood circulation and eliminating stasis blood part of going directly to enter thromboembolism focus thrombolytic blood vessel dilating, expel the blood stasis speckle be deposited in blood vessel wall, promote blood normal circulation, Fang Zhongyong Radix Astragali QI invigorating, Lignum Dalbergiae Odoriferae are regulated the flow of vital energy, the capable then blood of gas, the stagnation of QI then blood stasis, and blood circulation be unable to do without the promotion of gas, Fructus Lycii the kidney invigorating and Caulis Polygoni Multiflori, the same medicine must used with the fatty liver caused for treating hyperlipidemia of Rhizoma Alismatis in side, in side, the Radix Astragali, Radix Angelicae Sinensis are together with being Radix Angelicae Sinensis decoction for tonifying blood, and treatment QI and blood is two thanks to, myocardial ischemia, arrhythmia, because of Yin grows while yang is generating, and the prosperous hemopoietic of gas.There is albuminuria and with the situation of eyelid and edema of lower limbs in the laboratory test report often running into diabetes and hyperlipidemia complications patient clinically, so be aided with spleen reinforcing reinforcing the kindey to control nocturnal emission in side and can control Poria, the Rhizoma Alismatis of albuminuretic Semen Euryales and inducing diuresis to remove edema.One side is with powder Mian Ju road.So every angina pectoris caused because of dyslipidemia and disturbance of blood circulation, myocardial ischemia, fatty liver, arteriosclerosis, apoplectic hemiplegia, the diseases such as the ice-cold and albuminuria edema of trick fiber crops pain all can first-selected this medicine treatment.
Accompanying drawing illustrates: accompanying drawing is present invention process flow chart.
Claims (2)
1. one kind is by Fructus Crataegi with the medicine of pure Chinese medicine reduction hyperlipidemia, Radix Polygoni Multiflori Preparata, Hirudo, pure land dragon (going the assorted Pheretima of soil to be pure land dragon), Eupolyphaga Seu Steleophaga, the Radix Astragali, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Semen Persicae, Flos Carthami, Rhizoma Chuanxiong, Radix Et Rhizoma Rhei, Caulis Polygoni Multiflori, Caulis Spatholobi, Lignum Dalbergiae Odoriferae, Olibanum (processed), Myrrha (processed), Fructus Lycii, Semen Euryales (individual), Poria, Rhizoma Alismatis totally 22 kinds of natural Chinese medicines composition, and the gross weight be made up of 22 kinds of Chinese crude drugs 100% to calculate by weight percentage, the percentage ratio of each medicine is: Fructus Crataegi 15%, Radix Polygoni Multiflori Preparata 15%, Hirudo 6%, pure land dragon (going the assorted Pheretima of soil to be pure land dragon) 6%, Eupolyphaga Seu Steleophaga 6%, the Radix Astragali 6%, Radix Angelicae Sinensis 6%, Radix Salviae Miltiorrhizae 6%, Radix Paeoniae Rubra 3%, Semen Persicae 3%, Flos Carthami 3%, Rhizoma Chuanxiong 3%, Radix Et Rhizoma Rhei 3%, Caulis Polygoni Multiflori 3%, Caulis Spatholobi 3%, Lignum Dalbergiae Odoriferae 1%, Olibanum (processed) 1%, Myrrha (processed) 1%, Fructus Lycii 3%, Semen Euryales (individual) 2%, Poria 3%, Rhizoma Alismatis 2%.
2. compounding medicine method according to claim 1, comprises following 5 steps composition:
1. first Fructus Lycii is dried separately or dry for standby.
2. on clean threshing ground, fully mix even i.e. available pulverizer with Fructus Lycii be ground into fine powder by drying other 21 kinds of medical materials load weighted again, cross 80 mesh sieves (for save manpower can in pulverizer direct installation 80 mesh sieves).
3. the pill of every ball 0.2-0.3g size is made with pellet processing machine.
4. fine day can dry or dry, cloudy available oven for drying.
5. dry or enter bottle after drying, more stand-by with sealing machine sealing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310407448.0A CN104415187A (en) | 2013-09-02 | 2013-09-02 | Medicine for lowering hyperlipidemia by employing pure traditional Chinese medicines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310407448.0A CN104415187A (en) | 2013-09-02 | 2013-09-02 | Medicine for lowering hyperlipidemia by employing pure traditional Chinese medicines |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104415187A true CN104415187A (en) | 2015-03-18 |
Family
ID=52966010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310407448.0A Pending CN104415187A (en) | 2013-09-02 | 2013-09-02 | Medicine for lowering hyperlipidemia by employing pure traditional Chinese medicines |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104415187A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113456794A (en) * | 2021-08-25 | 2021-10-01 | 赵德昌 | Medicinal composition for removing obstruction in collaterals and removing blood stasis and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1902722A1 (en) * | 2005-07-12 | 2008-03-26 | Kabushiki Kaisha Yakult Honsha | Agent for elevating adiponectin concentration |
CN101167973A (en) * | 2007-10-26 | 2008-04-30 | 马万凯 | Traditional Chinese medicine for treating hyperlipemia |
CN102552573A (en) * | 2011-03-01 | 2012-07-11 | 张培轩 | Hypolipidemic medicament |
-
2013
- 2013-09-02 CN CN201310407448.0A patent/CN104415187A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1902722A1 (en) * | 2005-07-12 | 2008-03-26 | Kabushiki Kaisha Yakult Honsha | Agent for elevating adiponectin concentration |
CN101167973A (en) * | 2007-10-26 | 2008-04-30 | 马万凯 | Traditional Chinese medicine for treating hyperlipemia |
CN102552573A (en) * | 2011-03-01 | 2012-07-11 | 张培轩 | Hypolipidemic medicament |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113456794A (en) * | 2021-08-25 | 2021-10-01 | 赵德昌 | Medicinal composition for removing obstruction in collaterals and removing blood stasis and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103933353B (en) | A kind of medicine for the treatment of rheumatism, gout | |
CN103463528B (en) | Traditional Chinese medicine composition for treating chronic eczema | |
CN101209337B (en) | Medicinal liquor for treating rheumatism and rheumatoid | |
CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
CN102178800A (en) | Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
CN103784887A (en) | Traditional Chinese medicinal composition for treating kidney deficiency lumbago | |
CN103316295B (en) | Traditional Chinese composition for treating rheumatic arthritis | |
CN105012720A (en) | Traditional Chinese medicine composition for treating osteopathy | |
CN104258292A (en) | Drug for department of obstetrics and gynecology for treating pregnancy complication and manufacturing method thereof | |
CN103656377B (en) | A kind of Chinese medicine of internal and external application chronic prostatitis | |
CN101530515B (en) | Traditional Chinese medicine for treating diabetes mellitus complicated by intumescent prostate | |
CN102727779A (en) | Pharmaceutical composition for treating ovarian cysts and preparation method thereof | |
CN102657736B (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
CN104000933A (en) | Traditional Chinese medicine oral liquid for treating osteoproliferation | |
CN1074294C (en) | Process for making medical wine for treating rheumatism | |
CN102670977A (en) | Chinese medicinal composition for treating arthralgia, preparation method and applications of Chinese medicinal composition | |
CN104888134A (en) | Traditional Chinese medicine composition for treatment of haemorrhoids | |
CN101804183B (en) | Medicine for treating coronary heart disease | |
CN104415187A (en) | Medicine for lowering hyperlipidemia by employing pure traditional Chinese medicines | |
CN101085088A (en) | Traditional Chinese medicine formula for treating prostatic hyperplasia | |
CN1286500C (en) | Medication for treating numbness of the muscles and painful joints | |
CN102579672A (en) | Medicament for treating bone hyperplasia and lumbar disc herniation | |
CN106421603A (en) | Medicine for treating cardiovascular disease and preparation method thereof | |
CN102091165A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN101530593B (en) | Traditional Chinese medicine for treating diabetic numbness of extremities |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150318 |